Storebrand Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-102,632
Closed -$11.9M 876
2023
Q3
$11.9M Buy
102,632
+24,875
+32% +$2.67M 0.06% 336
2023
Q2
$8M Sell
77,757
-1
-0% -$106 0.04% 410
2023
Q1
$8.49M Buy
77,758
+9,588
+14% +$1.06M 0.04% 389
2022
Q4
$7.76M Sell
68,170
-2,675
-4% -$222K 0.04% 393
2022
Q3
$4.38M Sell
70,845
-18,375
-21% -$1.28M 0.03% 479
2022
Q2
$7.12M Sell
89,220
-3,907
-4% -$370K 0.04% 407
2022
Q1
$9.8M Sell
93,127
-112,268
-55% -$10.9M 0.05% 377
2021
Q4
$22.1M Buy
205,395
+14,306
+7% +$1.56M 0.1% 242
2021
Q3
$20.9M Sell
191,089
-8,220
-4% -$853K 0.1% 238
2021
Q2
$18.7M Buy
199,309
+6,373
+3% +$586K 0.09% 272
2021
Q1
$17.8M Buy
192,936
+144,187
+296% +$12.2M 0.09% 252
2020
Q4
$3.57M Buy
+48,749
New +$3.62M 0.02% 557

Other funds holding HZNP

Storebrand Asset Management's HZNP Position: Q4 2023 in Review

Storebrand Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 102,632 shares — an estimated $11.9M sold.

Storebrand Asset Management first reported a position in HZNP in Q4 2020 and held it in 12 quarters. The position peaked at $22.1M in Q4 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Storebrand Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Storebrand Asset Management sold 102,632 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $11.9M.
  • Storebrand Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and held it in 12 quarters.
  • Storebrand Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $22.1M in Q4 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Storebrand Asset Management's 13F filing for Q4 2023, filed 18 Jun 2026.